TC
GEN

TFS Capital’s Genesis Healthcare, Inc. GEN Stock Holding History

TFS Capital’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-186,663
Closed -$325K – 472
2017
Q2 		$325K Buy
186,663
+30,644
+20% +$65.1K 0.13% 319
2017
Q1 		$412K Buy
156,019
+129,001
+477% +$463K 0.13% 284
2016
Q4 		$115K Buy
27,018
+9,517
+54% +$31.4K 0.03% 621
2016
Q3 		$47K Sell
17,501
-193,087
-92% -$444K 0.01% 709
2016
Q2 		$373K Sell
210,588
-73,798
-26% -$151K 0.07% 496
2016
Q1 		$660K Sell
284,386
-51,260
-15% -$116K 0.1% 371
2015
Q4 		$1.17M Buy
335,646
+154,936
+86% +$742K 0.13% 280
2015
Q3 		$1.11M Buy
180,710
+122,917
+213% +$834K 0.11% 309
2015
Q2 		$381K Sell
57,793
-15,458
-21% -$104K 0.04% 618
2015
Q1 		$522K Buy
+73,251
New +$552K 0.05% 535

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return

TFS Capital's GEN Position: Q3 2017 in Review

TFS Capital sold out of Genesis Healthcare, Inc. (GEN) in Q3 2017, closing a stake of 186,663 shares — an estimated $325K sold.

TFS Capital first reported a position in GEN in Q1 2015 and held it in 10 quarters. The position peaked at $1.17M in Q4 2015. 73 funds tracked by Wall St. Rank hold GEN as of Q3 2017.

  • TFS Capital reported no remaining Genesis Healthcare, Inc. position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 186,663 Genesis Healthcare, Inc. shares in Q3 2017, an estimated $325K.
  • TFS Capital first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 10 quarters.
  • TFS Capital's Genesis Healthcare, Inc. position peaked at $1.17M in Q4 2015.
  • 73 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.